October 12, 2021
Chugai Pharmaceutical said on October 11 that it has filed its antibody cocktail Ronapreve (casirivimab + imdevimab), seeking special emergency approval for its label expansion for use as a COVID-19 prophylaxis and for the treatment of asymptomatic COVID-19. Ronapreve was...read more